Korjuny

catumaxomab · Atnahs Pharma Netherlands B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Korjuny, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: EMA Authorised: Korjuny (catumaxomab) — Atnahs Pharma Netherlands B.V.